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SUMMARY
Prospective surveillance was conducted in three remote Aboriginal communities with high rates
of rheumatic heart disease in order to investigate the epidemiology of group A b-haemolytic
streptococci (GAS). At each household visit, participants were asked about sore throat. Swabs
were taken from all throats and any skin sores. GAS isolates were emm sequence and
pattern-typed using standard laboratory methods. There were 531 household visits ; 43 diﬀerent
emm types and subtypes (emmST) were recovered. Four epidemiological patterns were observed.
Multiple emmST were present in the population at any one time and household acquisition rates
were high. Household acquisition was most commonly via 5- to 9-year-olds. Following
acquisition, there was a 1 in 5 chance of secondary detection in the household. Throat detection
of emmST was brief, usually<2 months. The epidemiology of GAS in these remote Aboriginal
communities is a highly dynamic process characterized by emmST diversity and turnover.
INTRODUCTION
Remote tropical Aboriginal communities of northern
Australia have among the highest reported rates of
acute rheumatic fever (ARF) and rheumatic heart
disease (RHD) in the world; yet, the epidemiology of
streptococcal infection in these settings appears to
diﬀer from that seen in temperate climates [1].
Speciﬁcally, symptomatic group A streptococcal
(GAS) pharyngitis is rare whereas GAS pyoderma is
common.
Much of what we know about the epidemiology
of GAS comes from studies conducted in temperate
climates [2–4], although there are data from tropical
and subtropical settings [5, 6]. One of the most com-
prehensive studies, with relevance to remote Ab-
original populations, was that done in the 1960s
and 1970s at the Red Lake Reservation [7]. Using
M protein serotyping, investigators demonstrated the
introduction, dissemination and waning of successive
serotypes in schoolchildren of an indigenous US
community. The mean number of new strain acqui-
sitions per child was 4.7 (range 1–9) per 24 months.
Some serotypes lingered in the community for ex-
tended periods whilst others moved rapidly through
the population. The phenomenon of rapid strain re-
placement has also been described in a US farming
community [8].
One of the limitations of M serotyping is the
proportion of strains that are non-typable, particu-
larly in Australian Aboriginal communities [9]. In the
1990s, Beall and others developed emm sequence
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typing based on the nucleotide sequence of the
variable 5k-end of the emm gene encoding for M pro-
tein. M serotypes and emm types appeared to be
concordant [10] and a comprehensive online emm
database is now available [11]. Bessen and others
have also used a polymerase chain reaction (PCR)-
based mapping technique to identify diﬀerent ar-
rangements of emm and related genes within the mga
regulon, or emm pattern typing. Patterns A–C are
associated with GAS strains recovered from the
throat, pattern D from the skin and pattern E from
both throat and skin [12]. With few exceptions, GAS
with a given emm sequence type have a predictable
emm pattern [13].
A previous longitudinal study of GAS epidemi-
ology in a remote Aboriginal island community also
used a typing method based on the mga regulon (vir
typing) [14]. This showed high strain diversity and
turnover. It also demonstrated simultaneous colon-
ization with multiple vir types and used a model to
estimate that each child carried a speciﬁc vir type for
an average of 4 months. We now report a longitudinal
study, using emm sequence typing, of three mainland
Aboriginal communities with exceptionally high rates
of ARF and RHD. One of the aims of the study was
to collect throat swabs and pyoderma swabs from
children in households at high risk for ARF. If any-
one subsequently developed ARF, it could be deter-
mined whether GAS pyoderma or GAS pharyngitis
was the antecedent infection. We also aimed to
examine the household and community epidemiology
of pharyngitis and pyoderma and determine whether
there were features unique to the study population,
including household and personal acquisition, length
of carriage, secondary transmission and the eﬀect
of age.
METHODS
Study sites and consultation
The study was conducted in three communities,
separated by at least 400 km, located in the Top End
of the Northern Territory (NT), Australia. At the
request of community elders, the community names
have not been disclosed. Each has an all-age preva-
lence of RHD >25/1000 population compared to
0.26/1000 in the non-Aboriginal population. A pro-
longed period of community consultation preceded
approval of the study protocol by the regional
ethics committee. Household and individual consent
was obtained and surveillance was commenced
in communities 1 and 2 in August 2003. Researchers
encountered logistic problems in community 2 and
the study was transferred to community 3 in June
2004. Surveillance was completed in July 2005.
Surveillance
Researchers endeavoured to visit each study house-
hold on a monthly basis. Each person present was
asked about sore throat and skin sores in the local
language. All throats were examined and swabbed for
culture. Limbs and exposed areas were also examined
and any pyoderma lesions swabbed according to a
standard protocol. Each individual episode was de-
ﬁned as a ‘consultation’. People with pyoderma,
symptomatic pharyngitis or other medical conditions
of concern were transported to the Community
Health Centre and provided with treatment. Speci-
mens were transported by air in a cold container to a
central laboratory.
Household units and deﬁnitions
It was not feasible to follow individuals over an ex-
tended period because of population mobility ; simi-
larly, a school-based study was impractical because
attendance was<50%. Households corresponded to
family groupings and were regarded as the primary
epidemiological units. In order to increase chances of
encountering further cases of ARF, study households
were selected because they had members with a
known history of ARF or RHD. A household was
deﬁned as a single family group that lived in one
house or two adjacent houses. Participants were con-
sidered to belong to a household if they said they be-
longed at enrolment and were present on at least two
subsequent visits. The number of people who were
seen only once in any household, as a ratio of house-
hold size, was used as a measure of household turn-
over. Because of the month-to-month variation in
the number of people present at each visit and vari-
ation in the number of successful visits (when data
and specimens were obtained) for each household,
the median number of visits and the consultations
per visit was calculated by household and by com-
munity.
For the purposes of this study, we have used
emmST to denote an emm type and emm subtype.
A household emmST acquisition was deﬁned as the
initial recovery of an emmST from any member of a
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household. A concurrent acquisition was the ﬁnding
of more than one person with the same emmST in the
household at the time of acquisition. Household per-
sistence was deﬁned as the length of time (months)
before an emmST was no longer detected in a house-
hold and did not reappear for the remainder of the
study period. A secondary event was the recovery
of an acquired emmST from another household
member at a subsequent visit, acknowledging that
this may be due to secondary transmission, re-
introduction or previously undetected concurrent ac-
quisition. Community persistence was deﬁned as the
time (in months) from ﬁrst detection of an emmST in
study households until no detection for o6 months,
or until the end of the observation period.
Laboratory methods
The methods used for culture and identiﬁcation of
b-haemolytic streptococci have been detailed in a
previous report [15]. The procedure for emm sequence
typing followed that recommended by the Centers for
Disease Control and Prevention (CDC) [11] with
minor modiﬁcations. We used InstaGeneTM matrix
(Bio-Rad, Hercules, CA, USA) for DNA sample
preparation; 20 colonies were harvested directly from
culture plates and resuspended in 200 ml of the
InstaGene matrix suspension. All other steps were
according to the manufacturer’s instructions. PCR
was conducted in 50 ml reaction volumes with 5 ml of
DNA sample, 5 ml dNTPs (2 mM), 1 ml each of primers
1 and 2 (25 mM), 2.5 U Taq DNA polymerase, 5 ml of
10r Taq buﬀer (Qiagen, Valencia, CA, USA), sdH2O
to 50 ml. PCR clean-up was done using QIAquick 96
PCR puriﬁcation kit (Qiagen) according to the man-
ufacturer’s instructions, eluting in 60 ml sdH2O.
For sequencing reactions we used the BigDye1
Terminator v. 3.1 Cycle Sequencing Kit (Applied Bio-
systems, Foster City, CA, USA) in a reaction volume
of 10 ml (2 ml puriﬁed PCR product, 0.5 ml primer
emmseq2, 4 ml premix and 3.5 ml sdH2O). Clean-up
was achieved by adding 10 ml sdH2O and using
DyeEx96 (Qiagen). The product was then desiccated
and sent to a commercial sequencing facility for sep-
aration. For sequence analysis, electropherograms
were viewed with the Lasergenef SeqMan software
v.7.0.0 (DNAstar, Madison, WI, USA) and sequences
were blasted against the Streptococcus pyogenes emm
sequence database on the CDC website [11]. New
(novel) emm sequences were submitted to the admin-
istrator for assignment. emm pattern typing of GAS
isolates was done according to the method of Bessen
and co-workers [16].
Data analysis
Epidemiological data were analysed using STATA 8
(Stata Corporation, College Station, TX, USA). The
Pearson product-moment correlation coeﬃcient was
used to assess correlations. Conﬁdence intervals were
calculated using standard methods. Because of dif-
ferences in surveillance time for the three communi-
ties, the variability of household visits and the number
of people seen at each household visit, rates were re-
ported per household visit and per consultations when
comparing households, and per 100 community con-
sultations when comparing communities.
RESULTS
Household surveillance
Forty-nine households and 1173 people were enrolled.
There were 531 household visits and 4842 consul-
tations. Household crowding was extreme in com-
munities 1 and 3 (Table 1). There were limited data
from community 2. The median household turnover
was 18% [interquartile range (IQR) 10–25] in com-
munity 1 and 31% (IQR 25–37) in community 3, al-
though the periods of surveillance diﬀered. Local
ceremonial events restricted surveillance in August
2004 and March 2005. Overall prevalence rates
for pharyngitis, GAS throat carriage and pyoderma,
by community and by age, have been reported else-
where [1].
Community dynamics of GAS
In total, 214 throat GAS isolates and 124 skin isolates
were emm sequence-typed and 43 emmST identiﬁed
(Table 2). Four novel emm subtypes were found,
emm58.8, emm91.1, emm99.5 and emm100.5. Twelve
of 28 emmST (43%) from community 1 were not
found in the other communities, as were 1/6 emmST
in community 2, and 12/26 (46%) in community 3
(Table 2). Thirteen emmST (emm 22, 25, 42, 44/61, 58,
78, 81, 97, 100, 101, 110, 114, stNS544) had been re-
ported from the same region in the mid-1990s [17].
The length of time each emmST was detected in the
study population varied greatly. A third of emmST
(14/43) appeared, increased in prevalence, peaked
and then departed from study households over a
period ofo6 months. Figure 1 shows this pattern for
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community 1. Nine emmST (21%) persisted in the
community for o10 months. By comparison, 18
emmST (42%) were seen at just one community visit,
often in several diﬀerent households, without detect-
able transmission within study households or to other
households. They were not encountered again. The
outbreak strain, emm55, arrived suddenly, dis-
seminated widely and peaked rapidly. It arrived in
community 3 households in February 2005 and was
ﬁrst detected in community 1 households a month
later. At both sites, outbreaks of acute post-
streptococcal glomerulonephritis (APSGN) followed
in its wake [18].
The median time an emmST remained detectable in
study households at each study site was 5 months
(IQR 1–9). For the last 12 months of the study, when
communities 1 and 3 could be directly compared, the
median number of emmST found in the study popu-
lation at any one time was 6.5 (IQR 4.8–8.3) in com-
munity 1 and 4 (IQR 3–7.5) in community 3.
Household dynamics of GAS
Household acquisition varied widely with a median of
5.5 (IQR 3.7–6.0) new emmST per household per year
in community 1 and 4.0 (IQR 3.6–6.8) in community
3. These crude rates are based on a median of 97 (IQR
86–140) consultations per house per year in com-
munity 1 and 89 consultations (IQR 69–131) in com-
munity 3. When rates for individual households were
adjusted for the number of visits and the number of
consultations, the median household acquisition rate
was 4.9 per household-year (IQR 4.2–9.1) for com-
munity 1 and 3.6 (IQR 1.9–7.9) for community 3.
There was strong correlation between emmST ac-
quisition per household year and household size
(Pearson correlation coeﬃcient=0.88, P<0.001 for
community 1, and 0.68, P<0.001 for community 3),
but not between acquisition and household turnover.
Six emmST were recovered just once (one individual
on one occasion), whilst seven emmST were recovered
from o10 households over the study period and
emm55 was recovered from 22 households.
We documented 216 household emmST acqui-
sitions, 141 via the throat, 72 via the skin and three
from both sites. However, these are acquisitions of
throat carriage compared to acquisitions of skin in-
fection; moreover, every study consultation included
a throat swab whereas skin swabs were only taken in
the presence of pyoderma. Figure 2 shows that the
individuals most likely to be responsible for a house-
hold acquisition were in the 5–9 years age group. On
20/216 occasions (9.3%, 95% CI 5.8–14) there was
concurrent household acquisition and on 41/216 oc-
casions (19%, 95% CI 13–25) the same emmST was
recovered from one or more other household mem-
bers at a subsequent visit (secondary event).
If the ﬁrst detected acquisition in a household is
regarded as the index case, there was no signiﬁcant
diﬀerence in secondary events depending on whether
initial GAS isolates had come from skin sores or
throat. There were 40 instances where we had ob-
tained serial swabs; an individual had an initial
negative swab (or no skin swab in the case of
Table 1. Comparative population and GAS isolate data from the three study communities
Community 1 Community 2* Community 3
No. of months in study 23 12 (1st year) 12 (2nd year)
Approximate community
population
2500 800 1800
Households enrolled 18 12 19
Median no. of people per
house (IQR)
17 (14–21) 7 (5–9) 14 (10–20)
Median visits per household
(IQR)
17.5 (16–19) 6 (4–7) 10 (8–10)
Median consultations per
household visit (IQR)
7.9 (7.1–11.5) 3.6 (2.5–5.2) 7.9 (6.2–11.0)
GAS throat isolates
per 100 consultations
133
4.4 (95% CI 3.7–5.2)
6
2.0 (95% CI 0.7–4.3)
75
4.9 (95%, CI 3.9–6.1)
GAS skin isolates
per 100 consultations
85
2.8 (95% CI 2.2–3.5)
5
1.7 (95% CI 0.5–3.9)
34
2.2 (95% CI 1.5–3.1 )
IQR, Interquartile range ; CI, conﬁdence interval.
* Note that there were relatively few GAS isolates from community 2.
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pyoderma) but was positive the following month and
was followed for consecutive months until the swabs
were again negative. On 34/40 occasions (85%) the
emmST was not recovered from the throat swab after
a month, in four people (10%), the emmST was de-
tected for 2 months. One person had emm55 isolated
for 3 months and another for 4 months. Otherwise, we
were not able to demonstrate prolonged carriage of
speciﬁc emmST. We found no examples of an emmST
moving from skin to throat and only one example of
an emmST moving from throat to skin.
There were seven conﬁrmed cases of ARF in study
households during the study period and in each case
we failed to recover GAS from the throat or skin of
Table 2. The diﬀerent emm types and subtypes identiﬁed in study households of the three communities
emmST
Community 1 Community 2 Community 3
TotalNo. Per 100 consults No Per 100 consults No. Per 100 consults
1 15 0.98 15
11 22 0.73 22
12 1 0.03 3 1.02 4
12.1 1 0.07 1
13L 1 0.03 4 0.26 5
15.1 4 0.26 4
19.4 2 0.07 2
22 13 0.43 2 0.13 15
25.1 2 0.07 1 0.34 3
33 10 0.33 2 0.13 12
42 3 0.20 3
44/61 11 0.72 11
53 2 0.13 2
55 24 0.79 28 1.83 52
56 1 0.07 1
58 1 0.07 1
58.8 8 0.26 8
71 17 0.56 1 0.07 18
75.1 8 0.26 8
76.6 5 0.17 2 0.13 7
77 1 0.07 1
78 4 0.13 7 0.46 11
81.2 1 0.34 2 0.13 3
87 1 0.03 1 0.07 2
91 10 0.33 4 0.26 14
91.1 3 0.10 3
97.1 4 0.26 4
98 4 0.13 4
99.5 6 0.20 6
100 11 0.36 3 0.20 14
100.5 1 0.03 1
101 2 0.13 2
103 15 0.50 2 0.68 1 0.07 18
105 1 0.03 1
110 3 0.10 3
114.2 3 0.10 1 0.34 1 0.07 5
116.1 2 0.68 2
123 7 0.23 7
st2904.1 10 0.33 5 0.33 15
stG653.1 5 0.17 1 0.07 6
stNS1033 17 0.56 17
stNS554 5 0.17 5
Total 219 (7.33) 10 (3.4) 109 (7.17) 338
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that person in the 2 months prior to presentation of
the illness. In four cases this was because the person
was absent from the household at the critical visits.
We recovered 29 isolates of GAS from other house-
hold members in the 2 months prior to the person
presenting with ARF, the month of presentation and
2 months following presentation (Table 3). They re-
presented 15 diﬀerent emmST.
Age and emmST and emm pattern-type distribution
There were no detectable diﬀerences in rates of com-
mon emmST with age. The proportion of pattern type
D decreased with age, from 44% of isolates in the 0–4
years age group to 25% in those aged o15 years,
presumably in relation to the declining prevalence of
pyoderma (Fig. 3). Pattern types A–C were more
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Fig. 1. Composite of the eight most common emm sequence types for community 1 households. The x axis indicates the
month and the y axis the number of GAS isolates as a proportion of the household consultations for that month.
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common in the early teenage years. The outbreak of
emm55 (pattern type A–C) mainly aﬀected the 10–14
years age group, involving 10.3% of that population,
compared to 3.4% of 0–4 years age group, 7.4% of
the 5–9 years age group and 1% of people agedo15
years.
DISCUSSION
A key ﬁnding of this study was the diversity of emmST
within households and across the region. There were
43 diﬀerent emmST overall with multiple emmST be-
ing present in the study population at any one time. In
the second year of the study alone, 38 separate
emmST were detected in a total study population of
just over 1000 people. Except for 15 isolates of emm1
in community 3, classic rheumatogenic emm types
were few. In this regard, the status of emm11 is un-
clear ; it was detected in the household of the ﬁrst case
of ARF reported in this study (Table 3). This emmST
has emm pattern type E and is serum opacity factor
(SOF) positive, characteristics unlike other rheuma-
togenic types. Yet M serotype 11 was recovered from
the throats of a number of people with ARF in
Trinidad in the 1970s [5]. Subsequently, it found its
way onto at least one published list of rheumatogenic
GAS serotypes [19] but has not been universally ac-
cepted as such [20].
Marked emmST diversity was found in a previous
study of an Aboriginal island community [17] and has
been reported from populations in Ethiopia, Brazil,
Thailand and India where rates of ARF and/or RHD
are relatively high [21–24]. Moderate diversity has
also been reported from Japan and Italy where the
rates of RHD are low [25, 26]. Contrasting reports
from temperate climate regions include a large study
of Pittsburgh schoolchildren that detected only 13
diﬀerent emmST over a 4-year period [4] and only 22
emmST were identiﬁed in a 2-year study of 202 fam-
ilies in Melbourne [27]. The number of diﬀerent
emmST seen in any one year in Salt Lake City
(population 180 000), where there has been enhanced
surveillance, is usually<20 [28].
It would be of no surprise to ﬁnd that genetic di-
versity is greatest where the community burden of
GAS is high and co-infection with multiple M types or
emmST is common. Horizontal gene transfer appears
to be the primary mechanism [29]. GAS are poly-
lysogenic – they contain multiple prophage ele-
ments – accounting for most of the variability
between strains, perhaps including factors that deter-
mine rheumatogenicity. Type-speciﬁc immune re-
sponses to epitopes of M protein put emm genes under
selective pressure. Thus, diversity is likely to be
greatest, with new types emerging more rapidly,
where the burden of colonization and infection is
highest. This has ominous implications for multi-
valent vaccine development, particularly for those
based on M protein determinants; only 103/338
(30%) of GAS isolates, and 11/43 (26%) of the
emmST in this study would have been covered by the
proposed 26-valent vaccine [30]. This also includes 72/
214 (34%) of GAS throat isolates.
Another ﬁnding of this study was the presence of 13
emmST that were previously reported in the Top End
more than a decade ago, none known to be a classic
rheumatogenic type. The persistently high rates of
skin infection in the region suggest that skin-tropic
strains are continuously cycling through these com-
munities. Shulman and others have proposed that the
decline in the incidence of ARF in the United States
was related to the replacement of rheumatogenic
strains by non-rheumatogenic strains [31]. Yet in the
study communities with sustained high rates of ARF,
persistence of recognized throat-tropic emmST or
rheumatogenic types has not been demonstrated, and
ARF outbreaks have never been reported. The inci-
dence of ARF does not even vary with season [14].
This raises the possibility that rheumatogenic de-
terminants, some perhaps independent of M protein,
could circulate in settings highly conducive to phage-
mediated lateral gene transfer between streptococcal
strains [29].
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hold introduction of new GAS emmST into the household
as a proportion of consultations in that age group ( )
compared to the reported period prevalence of pyoderma in
those age groups (2––2) [1].
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We distinguished four basic epidemiological pat-
terns although there was a degree of overlap. They
included a group of emmST that appeared to move
sequentially through the community over a 3- to
6-month period, emmST that persisted for a long
period of time, often more than a year, and emmST
that made brief single-month cameo appearances. The
fourth pattern was an outbreak. It is diﬃcult to de-
termine the extent to which these patterns are due to
properties of the organisms, the environment or the
host response.
Throat acquisition of an M type or emmST, and its
persistence, is not necessarily determined by type-
speciﬁc antibodies to M protein [32–34], yet type-
speciﬁc immunity does protect against disease [35].
Type-speciﬁc immunity is also highly variable from
individual to individual, both in strength of response
and duration, and is not necessarily determined by the
severity of the original infection [36]. As distinct from
reports elsewhere [4, 7], detection of each emmST in
the throat was almost always brief, a paradoxical
ﬁnding in view of the rates of ARF. This ﬁnding could
be due to limitations of data collection. It could also
be hypothesized that type-speciﬁc immunity leads to
low rates of persistence in individuals with greater
persistence in the community due to constant replen-
ishment of the non-immune pool through population
mobility. Similarly, a persistently high community
Table 3. GAS emmST recovered from other household members of the seven people in the study who had ARF;
emmST recovered during the month of presentation and 2 months either side
ARF
case no. x2 months x1 month
ARF
presentation
month +1 month +2 months
1 stNS1033 stNS554 11 — st2904.1
11 (two) 91.1
(22)* (21) (10) (24) (22)
2 — — — — StNS1033
(0) (15) (18) (8) (15)
3 25.1 22 (r2) 22 — 98
103 (two)
(8) (9) (16) (14) (18)
4 78 — — —
71 (9) (9) (2) (10)
(8)
5 — — 100 — 22
(9) (9) (7) (0) (14)
6 stNS1033 (three) stNS1033 76.6 — —
11 (two)
76.6
(14) (14) (24) (1) (16)
7 91 33 — — —
(15) (10) (1) (22) (14)
* The number of household consultations at each visit is shown in parentheses.
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turnover of emmST could modify the risk of an ARF
outbreak. Additional facets of the host response that
limit carriage could include non-type-speciﬁc im-
munity, such as to C5a peptidase and the hyaluronic
acid capsule.
The pattern of sequential M type (or emmST) re-
placement (shown in Fig. 1), has been demonstrated
elsewhere [4, 7, 14]. Similarly, strains that make a brief
appearance and vanish again are well known; their
contribution to disease burden is unclear, although
they contribute to genetic diversity. Some GAS
strains have an enhanced ability to disseminate and
cause disease, as demonstrated by the dramatic arrival
and dissemination of emm55. This pattern has pre-
viously been reported in the Top End and other parts
of the world [37].
The household holds the key to the epidemiology of
GAS. This was demonstrated in two classic studies of
the 1960s [38, 39]. Levine and co-workers cultured the
throats of all people who presented with a respiratory
illness on an airforce base in Maine, USA; if a
b-haemolytic streptococcus was recovered, patients
were divided into those with GAS and those who were
GAS-negative (some presumably having GCS/GGS)
[39]. They then cultured the throats of family contacts
living on the base and found that 48% of 244 child
contacts (aged 5–9 years) of elementary school-
children with GAS also harboured GAS compared to
2% of 115 child contacts of GAS-negative children
(P<0.002). On 72% of occasions (range 47–80%),
the GAS-positive patients and their culture-positive
contacts shared the same M serotype. The percentage
of positive family contacts was also higher in larger
families. The authors concluded that transmission of
GAS ‘requires a fairly direct and close degree of
contact between carriers and potential susceptibles,
and that in our society the major locus of this com-
bination of persons and the environment is the home’.
In our study, household acquisition and spread was
highly variable; nevertheless, we could not conclude
that GAS from pyoderma were more likely to be
transmitted than those from the throat. However, if
an individual introduced an emmST to a household,
there was a 1 in 5 chance of a secondary event at a
subsequent visit. In contrast, in a study of GAS
pharyngitis in Melbourne families, a primary case was
followed by at least one secondary case in 43% of
families [27] and the mean time to detection of a sec-
ondary case was 8 days. In our study, household visits
were usually a month apart ; as such we may have
missed a substantial proportion of secondary
transmissions. In their landmark study of GAS car-
riage and pharyngitis in Cleveland families, Dingle
and co-workers found that household acquisition of
an M serotype most commonly came through a child
aged <6 years [38]. This corresponds to the ﬁndings
of our study, and also corresponds with the peak age
group (5–9 years) of pyoderma in our study popu-
lation. In the Cleveland study, if the index case had
pharyngitis, then 25% of other household members
acquired the same organism, with illness being more
likely in younger children. If the index case had no
illness, the secondary carrier rate was 9%. In some
households the emmST persisted for many months,
sometimes years.
It has been proposed that the distribution of
emmST is determined by age, reﬂecting exposure to,
and acquisition of, immunity to common emmST [40].
Whilst we did not ﬁnd a clear age-dependent re-
lationship with individual emmST, we did demon-
strate a decline in the proportion of skin types with
age that probably reﬂects rates of pyoderma. It is not
clear how much of that decline is due to acquisition of
immunity or a reduction in other predisposing factors
such as scabies and local trauma.
This study shows that the epidemiology of GAS in
remote Aboriginal communities is a remarkably dy-
namic process with great emmST diversity, a multi-
plicity of emmST present in the community at any one
time, high household acquisition and secondary event
rates and a relatively short detection time. Four dif-
ferent epidemiological patterns were recognized at the
community level. Classic rheumatogenic GAS types
were largely absent and symptomatic pharyngitis was
rare. The hypothesis that skin infection plays a role in
the pathogenesis of ARF in remote Aboriginal com-
munities has yet to be proven. In the meantime, in-
adequate health awareness, crowded household
conditions and population mobility are likely to be
some of the driving forces behind GAS dissemination
and diversity within the region.
ACKNOWLEDGEMENTS
The authors are grateful for the advice and support of
Dr Edward Kaplan (University of Minnesota,
Minneapolis) and Dr Bernard Beall (Centers for
Diseases Control and Prevention, Atlanta). We also
wish to thank Doreen Jing-Garrarbirra, Lena
Djabibba, Ethelrida Dartinga, Hamish Cameron,
Melita McKinnon, Palave Dasari, the study families
Streptococcal dynamics in Aboriginal communities 537
and community health centre staﬀ for their contri-
butions. Murin Air (NT) and Western Pathology
provided assistance with transportation of specimens.
The study was supported by grants from the National
Heart Foundation of Australia (no. PB 02M 0996),
the National Health and Medical Research Council
(no. ID 251690) and the Cooperative Research Centre
for Aboriginal Health.
DECLARATION OF INTEREST
None.
REFERENCES
1. McDonald M, et al. Low rates of streptococcal phar-
yngitis and high rates of pyoderma in communities
where rheumatic fever is hyperendemic. Clinical Infec-
tious Diseases 2006; 43 : 683–689.
2. Wannamaker L. The epidemiology of streptococcal in-
fections. In : McCarty M, ed. Streptococcal Infections.
New York: Columbia University Press, 1954, pp. 157–
175.
3. Quinn R, Lowry P, van der Zwaag R. Signiﬁcance of
hemolytic streptococci for Nashville school children:
clinical and serologic observations. Southern Medical
Journal 1978; 71 : 242–246.
4. Martin JM, et al. Group A streptococci among school-
aged children: clinical characteristics and the carrier
state. Pediatrics 2004; 114 : 1212–1219.
5. Potter E, et al. Tropical acute rheumatic fever and as-
sociated streptococcal infections compared with con-
current acute glomerulonephritis. Journal of Pediatrics
1978; 92 : 325–333.
6. Majeed H, et al. Group A streptococcal strains in
Kuwait : a nine-year prospective study of prevalence
and associations. Pediatric Infectious Diseases Journal
1992; 11 : 295–300.
7. Anthony B, et al. The dynamics of streptococcal infec-
tions in a deﬁned population of children: serotypes as-
sociated with skin and respiratory infections. American
Journal of Epidemiology 1976; 104 : 652–666.
8. Kaplan EL, Wotton JT, Johnson DR. Dynamic epi-
demiology of group A streptococcal serotypes associ-
ated with pharyngitis. Lancet 2001; 358 : 1334–1337.
9. Hartas J, et al. Characterisation of group A strepto-
coccal isolates from tropical Australia with high pre-
valence of rheumatic fever : probing for signature
sequences to identify members of the family of serotype
5. Microbial Pathogenesis 1995; 18 : 345–354.
10. Beall B, Facklam R, Thompson T. Sequencing emm-
speciﬁc PCR products for routine and accurate typing
of group A streptococci. Journal of Clinical Micro-
biology 1996; 34 : 953–958.
11. Centers for Diseases Control and Prevention (CDC).
Streptococcus laboratory. Atlanta, Georgia, USA
(http://www.cdc.gov/ncidod/biotech/strep/strepindex.
htm). Accessed 2 January 2007.
12. Bessen D, et al. Genetic correlates of throat and skin
isolates of group A streptococci. Journal of Infectious
Diseases 1996; 173 : 896–900.
13. McGregor KF, et al. Group A streptococci from a re-
mote community have novel multilocus genotypes but
share emm-types and housekeeping alleles with isolates
from worldwide sources. Journal of Infectious Diseases
2004; 189 : 717–723.
14. Carapetis JR. Ending the heartache: the epidemiology
and control of acute rheumatic fever and rheumatic
heart disease in the Top End of the Northern Territory
[Ph.D. Thesis]. Sydney: University of Sydney, 1998.
15. McDonald M, et al. Recovering streptococci from the
throat in remote tropical communities : a practical
alternative to direct plating. Journal of Clinical Micro-
biology 2006; 44 : 547–551.
16. Bessen DE, et al. Contrasting molecular epidemiology
of group A streptococci causing tropical and non-
tropical infections of the skin and throat. Journal of
Infectious Diseases 2000; 182 : 1109–1116.
17. McGregor KF, et al. Multilocus sequence typing of
Streptococcus pyogenes representing most known emm
types and distinctions among subpopulation genetic
structures. Journal of Bacteriology 2004; 186 : 4285–
4294.
18. Williams S, Markey P. Acute post streptococcal glom-
erulonephritis in a remote community. Northern Terri-
tory Diseases Control Bulletin 2005; 12 : 16–18.
19. Massell B. Rheumatic Fever and Streptococcal Infection.
Boston: Countway, 1997, p. 193.
20. Bisno A. Group A streptococcal infections and acute
rheumatic fever. New England Journal of Medicine
1991; 325 : 783–793.
21. Abdissa A, et al.High diversity of group A streptococcal
emm types among healthy schoolchildren in Ethiopia.
Clinical Infectious Diseases 2006; 42 : 1362–1367.
22. Teixeira LM, et al. Genetic and phenotypic features of
Streptococcus pyogenes strains isolated in Brazil that
harbor new emm sequences. Journal of Clinical Micro-
biology 2001; 39 : 3290–3295.
23. Pruksakorn S, et al. Epidemiological analysis of non-
M-typeable group A Streptococcus isolates from a Thai
population in northern Thailand. Journal of Clinical
Microbiology 2000; 38 : 1250–1254.
24. Sharma M, et al. Heterogeneity of community based
paediatric GAS isolates from India : challenges to the
multivalent vaccine. In: Sriprakash KS, ed. Strepto-
cocci – New Insights into an Old Enemy. Amsterdam:
Elsevier, 2006, pp. 49–53.
25. Tanaka D, et al. emm typing of group A streptococcus
clinical isolates : identiﬁcation of dominant types for
throat and skin isolates. Microbiology and Immunology
2002; 46 : 419–423.
26. Dicuonzo G, et al. Group A streptococcal genotypes
from pediatric throat isolates in Rome, Italy. Journal of
Clinical Microbiology 2001; 39 : 1687–1690.
27. Danchin MH. Disease burden and management of
group A streptococcal pharyngitis in primary care in
538 M. I. McDonald and others
Australia. Department of Paediatrics [Ph.D. Thesis].
Melbourne: University of Melbourne, 2006.
28. Miner LJ, et al. Molecular characterization of Strepto-
coccus pyogenes isolates collected during periods of in-
creased acute rheumatic fever activity in Utah. Pediatric
Infectious Diseases Journal 2004; 23 : 56–61.
29. Davies MR, et al. Evidence for increased horizontal
gene transfers among streptococci from group A
streptococcal endemic regions. In : Sriprakash KS, ed.
Streptococci – New Insights into an Old Enemy.
Amsterdam: Elsevier, 2006, pp. 188–192.
30. Hu MC, et al. Immunogenicity of a 26-valent group A
streptococcal vaccine. Infection and Immunity 2002; 70 :
2171–2177.
31. Shulman S, et al. Temporal changes in streptococcal M
protein types and near-disappearance of acute rheu-
matic fever in the United States. Clinical Infectious
Diseases 2006; 42 : 441–447.
32. Dunlap M, Harvey H. The carrier state and type-speciﬁc
immunity in streptococcal disease. American Journal of
Diseases of Children 1967; 114 : 229–243.
33. Guirguis N, et al. Type-speciﬁc immunity and pharyn-
geal acquisition of group A streptococcus. American
Journal of Epidemiology 1982; 116 : 933–939.
34. Kaplan E, et al. Two year persistence of group A strep-
tococci (GAS) in the throat accompanied by falling
streptococcal antibody titers : the upper respiratory
carrier state conﬁrmed and microbiologically/immuno-
logically examined. Proceedings of the XVIth Lanceﬁeld
International Symposium on Streptococci and Strepto-
coccal Diseases. Palm Cove, Queensland, Australia,
2005.
35. Wannamaker L, et al. Studies on immunity to strepto-
coccal infections in man. American Journal of Diseases
of Children 1953; 86 : 347–348.
36. Lanceﬁeld R. Persistence of type-speciﬁc antibodies in
man following infection with group A streptococci.
Journal of Experimental Medicine 1959; 110 : 271–292.
37. Dillon H. Post-streptococcal glomerulonephritis fol-
lowing pyoderma. Reviews of Infectious Diseases 1979;
1 : 935–945.
38. Dingle J, Badger G, Jordan W. Streptococcal infections.
In : Illness in the Home: A Study of 25,000 Illnesses in a
Group of Cleveland Families. Cleveland: Press of
Western Reserve University, 1964, pp. 97–117.
39. Levine J, et al. Studies on the transmission within fam-
ilies of group A hemolytic streptococci. Journal of
Laboratory and Clinical Medicine 1966; 67 : 483–494.
40. Jaggi P, et al. Age inﬂuences the emm type distribution
of pediatric group A streptococcal pharyngeal isolates.
Pediatric Infectious Diseases Journal 2005; 24 : 1089–
1092.
Streptococcal dynamics in Aboriginal communities 539
